ライフサイエンスコーパス: age

1 mortality rates both between 1992 and 1998 (age-standardised mortality ratio in men aged 20-69 years

2 MATERIAL/Forty-five stroke patients and 45 age- and sex-matched controls were recruited.

3 ticipants (means +/- SDs: BMI: 33.3 +/- 4.6; age: 63.8 +/- 6.3 y; 83% women) were recruited between J

4 oteins (MBGs) in 65 children with ASD and 65 age-matched typically developing (TD) children were comp

5 difficulties, by contrast, persisted across age, as observed within two independent PGC-SCZ2 subsamp

6 r HPV vaccination, with 3-dose uptake across age cohorts being about 50%-77%).

7 Seven hundred one adults age 35 and above years were participated with a response

8 Adults aged 18 to 69 years from NHANES (National Health and Nut

9 as severe or moderate to severe) for adults aged 60 years or older (n = 16,770) over 3 time periods

10 METHOD: Adults aged 18-65 with treatment-naive major depression were ra

11 randomly assigned (2:1) healthy Thai adults aged 18-49 years with a computer generated randomisation

12 In our cohort, advanced age (>67) was the strongest predictor of overall (OS) an

13 patients considered "too well" were advanced age, male sex, university hospital admission, comorbidit

14 With advancing age, an increased visibility of perivascular spaces (PVS

15 that recombinant I62-CFH (protective against age-related macular degeneration) and V62-CFH functioned

16 cess cases (included 156 cases) affected all age groups regardless gender predilection.

17 determinant of orangutan movement among all age and sex classes, with orangutans more likely to move

18 ough biotic and abiotic degradation, and all age groups are exposed not only to BDE-209 and -99 but a

19 n striatal dopamine transporter binding (all age ranges in caudate and putamen, p<0.0001) and (18)F-F

20 accine interventions are cost saving for all age and risk groups.

21 wing an SSO event, with positive ORs for all age groups and for three of the four counties.

22 other age ranges, p<0.0001; in putamen: all age ranges, p<0.0001).

23 uld provide piperaquine exposures across all ages comparable to the exposure currently seen in a typi

24 ormance) can be acquired and mastered at all ages.

25 study, 74 participants with peanut allergy (ages 4-25 years) were treated with placebo (n = 25), Via

26 lead to therapeutic advances that ameliorate age-related neurodegenerative pathologies.

27 omy-related reduction in GFR, followed by an age-related decline that may be more rapid in related do

28 data of hepatitis B in China, we propose an age- and time-dependent discrete model and use the metho

29 Our results suggest an age-specific difference in human postvaccination respons

30 e (21% vs. 31% and 49%, respectively) and an aging workforce that is less likely to be in private pra

31 ities to improve health and longevity for an aging global population.

32 cular event affecting most individuals in an aging population, there is little consensus regarding it

33 With an aging ESRD population and continued organ shortage, pres

34 In univariate analysis, age >60 years, radiation dose, bilateral ocular involvem

35 e of diagnosis before 2007 or after 2013 and age <18 years.

36 In regression models, APOE-e4 dose and age both consistently increased risk, as did lower educa

37 s with common eye diseases like glaucoma and age-related macular degeneration.

38 e-surgical TLE patients (7 MRI-negative) and age-matched healthy volunteers were scanned at 7T.

39 tions in older men with low testosterone and age-associated memory impairment (AAMI).

40 auditory neurons in mature (2-4 months) and aged (20-26 months) mice.

41 pproach for studying its role in disease and aging.

42 Repeated cell divisions and aging impair stem cell function.

43 decreases in the amygdala as people with ASD age into adulthood, a phenomenon not found in TD.

44 mass index (BMI; weight (kg)/height (m)2) at age 18-21 years, BMI at baseline, and change in BMI diff

45 omes on discharge to home, at 1 year, and at age 18 to 24 months' PMA and neurodevelopmental assessme

46 1) and school attendance/home environment at age 7-14 years.

47 tion z score) on child cognitive function at age 7-14 years (i.e., joint mediators beta = -0.07, 95%

48 ycemia, oxidative stress, and nephropathy at age 20 weeks compared with their db/m littermates.

49 incident ischaemic strokes, 369 occurred at age >/=80 years, of which 124 (33.6%) were in non-antico

50 ct effects mediated through later poverty at age 7-14 years (beta = -0.01, 95% confidence interval: -

51 Calculus, pocket, or bleeding presence at age 24 years separately presented fair accuracy.

52 screening method, initiation of screening at age 40 years, 5-year re-screening and 3-year surveillanc

53 k with allergic disease and lung function at ages 12 and 18 years.

54 ending, respectively, as adverse outcomes at ages 15-35 years.

55 saliva samples from 55 male college athletes ages 18-25 years.

56 were male and 1 (8%) female, with an average age of 18.2 years.

57 by 2014, resident women </=33 years had been age-eligible for HPV vaccination, with 3-dose uptake acr

58 Being exposed to poverty before age 7 years had a larger direct effect (difference in co

59 erimental data suggest a correlation between age at disease onset, response to sodium channel blocker

60 centile for cumulative risk exposure between ages 6 and 24 years) of systolic BP, total-cholesterol,

61 ent is adequate for normal bone gain between ages 8 and 16 y.

62 portant roles in neurodegeneration and brain aging.

63 xamined cross-sectional differences in MD by age and menopausal status in over 11,000 breast-cancer-f

64 (LYGs) over the study period, stratified by age, sex, and race.A 1-y MMC in 2015 would increase the

65 <0.0001) and (18)F-FDOPA uptake (in caudate: age </=50 years, p=0.0002; all other age ranges, p<0.000

66 Among infants and children aged 9 to 48 months with nutritional iron-deficiency ane

67 est case fatality (39%) was seen in children aged younger than 5 years.

68 rogression among Bedouin and Jewish children aged <12m declined 74% (55-85%) and 43% (4-68%), respect

69 ent PD cases and 118,095 comparable controls aged > 65 years in 2009 using Medicare claims data.

70 t benefit in decreasing IBTR across all DCIS age groups, similar to that seen in patients with invasi

71 Results Mean (+/- standard deviation) age, and body mass index were 57.5 (+/- 10.1) years and

72 pography of a cuticular drusen distribution; age-dependent variations in cuticular drusen phenotypes,

73 ion on retinal structure and function during aging.

74 We generated distinct sets of rules for each age group to capture the temporal differences seen in th

75 Our model, which estimates age based on DNA methylation at 329 unique CpG sites, ha

76 (premenopausal and postmenopausal females), age (prepubertal children), and the presence of hypoxia

77 Estimation Algorithm) software, adjusted for age at baseline data collection.

78 Cox proportional hazards models adjusted for age, sex, AMD severity, VA, history of cataract surgery,

79 egions were compared by ANCOVA, adjusted for age.

80 Cox proportional hazards model adjusting for age, sex, race, and comorbidity.

81 After adjustment for age, sex, country, and SCD phenotype, a low hemoglobin l

82 ene expression, including CD8(+) T cells for age and CD4(+) T cells and monocytes for sex, we detecte

83 mothers had not smoked after correction for age, sex, birth weight, height, body weight, Tanner stag

84 nt an automated method to extract labels for age, gender, and tissue from textual metadata and GEO da

85 gs (and no GBCA administration), matched for age and sex, were inculded.

86 FOXP3mRNA expression ex vivo decreased from age 4.5 to 6 years (P(U,LPS) < 0.001; P(PI) = 0.051; P(F

87 Samples from age-matched non-neuropathic individuals were used as con

88 sed to include patients of different gender, age, wound duration and type of surgery (general, vascul

89 ) of 14 678 babies born before a gestational age of 32 weeks developed severe necrotising enterocolit

90 Among babies born before a gestational age of 32 weeks, the adjusted network incidence of necro

91 ate, infant's date of birth, and gestational age.

92 METHODS AND At gestational age mean 32 weeks (early) and mean 37 weeks (late), we c

93 were acquired at 29 to 34 weeks gestational age.

94 rth, low birth weight, small-for-gestational-age births, cesarean delivery, and low Apgar score.

95 ng transplant patients (n = 18), and healthy aged-matched controls (n = 10).

96 n naturally conceived sheep, and our healthy aged cloned sheep.

97 on, whereas the host traits considered here (age and previous carriage) accounted for less than 5%.

98 ldwide highlights the need to understand how aging promotes CVD in order to develop new strategies to

99 The transition from the last ice age to the present-day interglacial was interrupted by t

100 re 1.44 times higher per 10-year increase in age (odds ratio [OR], 1.44; 95% confidence interval [CI]

101 The patients ranged in age from 19-89 years.

102 of >/= 1 cm did not differ significantly in age, race, or duration of follow-up.

103 ell deletion rejuvenates pulmonary health in aged mice.

104 Sesn2 and AMPK upstream LKB1 is impaired in aged hearts during ischemia (P < 0.05 vs. young hearts).

105 Augmenting P2Y14 R expression levels in aged/diseased hCPCs antagonizes senescence and improves

106 neurons, effects that were also observed in aged mice, albeit to a lesser extent, indicating preserv

107 Decreased Sesn2 levels in aging lead to a blunted ischemic AMPK activation, altera

108 A number of factors, including age, sex, and genotype, may affect these metabolic proce

109 sing scan quality (P < .001), and increasing age (P < .03).

110 Among individuals aged 18 to 34 years, frequent indoor tanners (>/=10 time

111 in these communities, we invited individuals aged between 35 and 70 years who intended to live at the

112 nrelated hematologically normal individuals (ages 55 to 101 years).

113 thy1-cre mouse (NEGSKO mouse) and at a later age by breeding with a CaMKII-ERT2-Cre (FIGSKO mouse).

114 ariations in chlorophyll a:b ratio with leaf age and physiological stress, a further separation of to

115 is regarded as a disease of accelerated lung aging.

116 s) and 95% CIs, after adjusting for maternal age, country of origin, educational level, cohabitation

117 regression analyses, adjusting for maternal age, ethnicity, birth country and weight, as well as inf

118 Mean age was 70+/-9 years, and 50% were female.

119 and Methods Adult patients (n = 13 096; mean age, 42 years; age range, 15-95 years) admitted with BAP

120 en trials (n = 40058; range, 142-16608; mean age, 53-79 years) were included.

121 eriod, 2763 (6.6%; 95% CI: 6.3%, 6.8%) (mean age, 48.1 years +/- 18.1; range, 15-102 years) had a new

122 contained 1 738 886 participants with a mean age of 55.6 years (SD 9.7), 59.5% of whom were women.

123 with a previous revascularization had a mean age of 66 years, 73% were male, and the median baseline

124 e modified intention-to-treat analysis (mean age, 52 [SD, 14] years; 75 women [35%]).

125 >/=60 ml/min per 1.73 m(2) At baseline, mean age was 55 years old, 37% of participants were men, and

126 with and diabetic patients without DPN, mean age (60 years [range, 38-79 years] vs 61 years [range, 4

127 l of 1123 subjects (593 [52.8%] female; mean age, 67.1 years +/- 8.7 [standard deviation]) underwent

128 asurement, and 992 (521 [52.5%] female; mean age, 67.1 years +/- 8.7) underwent FD and T1 measurement

129 s with nonvalvular atrial fibrillation (mean age, 74.7 years [SD, 10.8]; men, 55.8%; NOAC dabigatran,

130 908 patients with acute HF (1,186 male; mean age 75.66 +/- 11.74 years).

131 s with lymphomas (45 females, 70 males; mean age of 46 years).

132 Among the 136 randomized participants (mean age, 50.4 [SD, 13.3] years; 42% women), 113 (83%) comple

133 Among 336 randomized patients (mean age, 68 years; 16% women), 333 completed the trial.

134 een May and December 2015, 10 patients (mean age, 70.4 years; range, 58-82 years) with biochemical pr

135 consented to participate in the study (mean age, 86 years; 76% female) and 359 had 840 falls in 43 m

136 in the laboratory risky decision task (mean age, 34.2 [10.3] years), 44 (59%) were women and 54 had

137 The mean age of participants was 69 years, 76% of participants we

138 67% male, 84% non-Hispanic white, with mean age+/-SD 62+/-11 years; 16% (n=237) were cognitively imp

139 Twenty-three women (mean age +/- standard deviation, 61.7 years +/- 13.8) were re

140 Median age of the study cohort was 46 (interquartile range, 32-

141 Median age was 41 years (interquartile range: 27 to 53 years) w

142 ldren (693 girls and 725 boys) with a median age of 27 months (interquartile range, 12-69 months).

143 3 patients, 551 (63.9%) were male and median age was 58 years (interquartile range, 51-68 years).

144 d patients with and without delirium (median age, 63 yr; range, 23-84) who were assessed with the Edi

145 In these patients, median age was 58 years (IQR 51-62), median number of previous

146 The median age in the MFS group was 35.4 years versus 35.6 years in

147 The median age of the patients was 66 years, and 72% were men; 43%

148 998 (age-standardised mortality ratio in men aged 20-69 years in fast vs slow privatised towns: 1.13,

149 early to middle age and a low BMI in middle age may be positively associated with ALS risk.

150 A decreasing BMI from early to middle age and a low BMI in middle age may be positively associ

151 lity criteria (ie, brain metastases, minimum age, HIV infection, and organ dysfunction and prior and

152 that extensive long-term culture-induced MSC aging impaired their osteogenic ability and subsequent b

153 ed number of patient characteristics, namely age, sex, and ethnicity; however, several patient-level

154 ed conditional knockout [cKO]) and naturally aged mouse models.

155 mitophagy is thought to contribute to normal aging and to various neurodegenerative and cardiovascula

156 -driver mutations (CHDMs) occurs with normal aging and these mutations have been detected in more tha

157 nces may be related to a modifying effect of age, time since menopause, and HT formulation.

158 fic cell populations mediated the effects of age and sex on gene expression, including CD8(+) T cells

159 lung lining fluid composition independent of age or genotype.

160 allergy were observed already at 1 month of age, when the IgA antibodies are predominantly maternall

161 on the development of RW before 13 months of age.

162 pertussis vaccine by the end of 15 months of age.

163 and characterise an epigenetic predictor of age in mice, the mouse epigenetic clock.

164 Immunosenescence is a series of age-related changes that affect the immune system and, w

165 BVE(Cyp24a1-wt)) developed PTC at 5 weeks of age.

166 e standard infant vaccines at 6 and 10 wk of age or to provide standard infant vaccines without HRV.

167 MEP concentrations at 5 and 8 y of age were associated with higher child adiposity, but ear

168 psychological development scores at 4-5 y of age were estimated with the use of the McCarthy Scales o

169 sed 152 masters athletes 54.4+/-8.5 years of age (70% male) and 92 controls of similar age, sex, and

170 (CIS) with disease onset before 18 years of age and duration of less than 4 years were included in t

171 A total of 42 080 individuals 40 years of age and older participating in 14 population-based cohor

172 of employed men and women 18 to 74 years of age at baseline examination in 1967 to 1973.

173 improved respiratory function at 11 years of age compared with children treated with placebo.

174 Mullen scores at 2 years of age differed significantly between clusters.

175 Among women 45 to 64 years of age in ARIC and REGARDS, age-adjusted hazard ratios comp

176 rn period and in lung function at 8 years of age in children whose birth was extremely premature.

177 tterns were present among men >/=65 years of age in CHS and REGARDS.

178 l of 113 participants older than 50 years of age with a range of AMD severity.

179 d seventy-eight women from 25 to 76 years of age with increased breast cancer risk who underwent CE s

180 both sexes; pediatric cases (</=16 years of age) accounted for 10.1%.

181 mple of individuals (N = 347, 18-59 years of age) completed a battery of behavioral measures, psychia

182 51 males, mean +/- SD 24.1 +/- 3.1 years of age) showed similar sulci patterns, which allowed us to

183 according to age (among donors <70 years of age), sex, or height (among donors </=190 cm tall).

184 onthly MIT at <15, 15-64, and >/=65 years of age, respectively, while the average increase in the mon

185 ranging from less than 1 year to 93 years of age.

186 might further clarify the prognostic role of aging.

187 r care should be taken in the 30-50-year-old age group, due to their significantly increased risk of

188 markers of inflammation, we argue that old, age-associated, aggregated proteins in neurons can induc

189 Older age, female sex, preference for English, more education,

190 in eyes with a thinner RNFL thickness, older age, and decreased scan quality.

191 nferior factors in questionnaires were older age and female sex ( P < .01).

192 The barriers to cataract surgery were older age, greater distance to the hospital, municipalities wi

193 d differences were typically larger at older ages and similar in magnitude in each cohort.

194 erval 1.03-1.14), regardless of HR status or age.

195 audate: age </=50 years, p=0.0002; all other age ranges, p<0.0001; in putamen: all age ranges, p<0.00

196 ce for association with the primary outcome: age, vasopressor requirement, thrombocytopenia, preexist

197 Similar trends were seen in outpatients aged >/=5 years and pediatric admissions.

198 ere 63 new cases of IIH, yielding an overall age- and gender-adjusted annual incidence of 1.8 per 100

199 time of birth (P = 0.001), but not parental age nor maternal gestational weight gain, were associate

200 lled, parallel-group trial, 401 participants aged 6 to 11 years were randomized to receive once-daily

201 ndary objectives are to determine if patient age, and first or second eye surgery affect intra-operat

202 Mean (SD) patient age was 62.1 (20.3) years for ambulatory vs 48.1 (22.3)

203 t- and implant-related factors (sex, patient age, smoking, number of remaining teeth, percentage of t

204 Study sample size, patient age, follow-up time, timing of MRD assessment (postinduc

205 IRs among patients aged 0-4 years were more than double overall IRs.

206 the odds of in-hospital death among patients aged 18-49 years (adjusted odds ratios [aOR] = 0.21; 95%

207 Twenty-four case patients aged 5-18 years and appropriate control patients with no

208 METHODS AND Twenty-five patients aged median 12.0 years after repair of tetralogy of Fall

209 thousand fifteen randomly selected patients aged 45-75 y without PA contraindications were invited.

210 point, randomised controlled trial, patients aged 70 years or younger with aphasia after stroke lasti

211 We enrolled adult patients (aged >/=18 years) who had cytologically or histologicall

212 rTOF patients, aged 13.0+/-2.9 years, had higher indexed right ventricu

213 n a general population sample of 2415 people aged 40 years and over in Australia.

214 ollegiate and professional football players (age range, 52-65 years) provided informed consent to par

215 We used donors/100 000 population age 18 to 84 years (D/100K) as a measure of equity.

216 he anomalous current declines with postnatal age, PIEZO2 may contribute to hair cell development, but

217 we have extended these analyses to prenatal ages and additional brain regions.

218 TBI (<0 mg/kg) in preschool children (PSC) (age range: 6-59 mo) and women of reproductive age (WRA)

219 girls [48.0%]; median [interquartile range] age, 12.9 [11.2-15.3]), of whom 684 were randomized to t

220 ndomized to the rotating arm (median [range] age, 65 [44-87] years) and 49 patients to the control ar

221 ange) follow-up in 68 adults (median [range] age, 66 [48-83] years; 19% female) was 38 (2.5-39) month

222 patients to the control arm (median [range] age, 67 [38-82] years).

223 n 45 to 64 years of age in ARIC and REGARDS, age-adjusted hazard ratios comparing blacks versus white

224 s) are necessary interventions to rejuvenate aged/diseased cells and improve their regenerative capac

225 for small-scale societies for which reliable age records are difficult to acquire.

226 ge range: 6-59 mo) and women of reproductive age (WRA) (age range: 15-49 y).Cross-sectional data for

227 es, respectively, than did men of respective ages).

228 pose an extraordinary threat to the world's aging population, yet no disease-modifying therapies are

229 elation between DNA fragmentation and sample age over the timespans analyzed, even when controlling f

230 The mean (SD) age at diagnosis for the 65 057 women included in the an

231 The mean (SD) age at end of follow-up was 4.6 (0.40) years for the 613

232 The mean (SD) age of the participants at the antenatal interview was 3

233 SVG, 2803 (19%) were women and the mean (SD) age was 68 (8.9) years.

234 In the study cohort, the mean (SD) age was 69.6 (12.1) years among 1105356 patients (40.2%

235 were male and all were white; the mean (SD) age was 69.7 (14.1) years.

236 tients (12822 women and 17001 men; mean [SD] age, 44.9 [12.0] years).

237 Of the 43249 patients with AML (mean [SD] age, 59.5 [16.6] years; 23939 men and 19310 women), 1127

238 the Mainsail trial were included (mean [SD] age, 68.7 [7.89] years).

239 nts with cSCC (19 men and 5 women; mean [SD] age, 76.4 [12.2] years) detected increased PD-1 and PD-L

240 elationship, adjusting for demographic (sex, age, race, ethnicity), socioeconomic (income, education,

241 No significant aging effect was observed in [(18) F]Nifene binding over

242 of age (70% male) and 92 controls of similar age, sex, and low Framingham 10-year coronary artery dis

243 changes and their importance among specific age and sex groups are still poorly understood.

244 e study population comprised 76,188 subjects aged 16-89 years at recruitment.

245 Seventy-one subjects (ages, 55-76 yr; apnea-hypopnea index, 0.2-96.6 events/h)

246 ry artery calcium score was more likely than age to provide higher category-free net reclassification

247 The age distribution of measles cases changes in response to

248 The age range of the patients was 18-45 years with a mean (+

249 associated with LTL in offspring across the age range, or when considering only young lambs (n = 164

250 val [UI], 55.2 to 60.0) will be obese at the age of 35 years, and roughly half of the projected preva

251 matory bowel disease unclassified before the age of 10 years, the disease is complex, multifactorial,

252 We determined the age- and sex-adjusted risk of death for each type of syn

253 of non-linear least squares to estimate the age-specific annual rate of HBsAg seroclearance.

254 The outcome of interest was the age-adjusted incidence of HPV-related cancer (both cervi

255 ients and health care systems, and given the aging of the population worldwide, the incidence of fall

256 e of the enzyme acid sphingomyelinase in the aging of stored units of packed red blood cells (pRBCs)

257 e deamination follows a conventional thermal age model, but we find no correlation between DNA fragme

258 eases for those older than 65 than for those aged 18-39.

259 on investment, high-risk groups of the three age group subpopulations can be prioritized for vaccinat

260 GFR did not vary significantly according to age (among donors <70 years of age), sex, or height (amo

261 to high body-mass index (BMI), according to age, sex, cause, and BMI in 195 countries between 1990 a

262 c brain changes on gait speed in addition to age, sex and hypertension independent from brain atrophy

263 icity in the nucleus accumbens is central to age-related changes in voluntary running.

264 in cementum density ( P = 0.009) compared to age-matched healthy control teeth.

265 0.05) in women suffering rUTIs, compared to age-matched healthy controls with concentrations further

266 s (a) greater in young ASD cases compared to age-matched TD controls (<18 years old) and (b) decrease

267 dings indicate prenatal WD exposure leads to age-specific changes in voluntary physical activity in f

268 cross-links in genomic DNA may contribute to aging, neurodegeneration, and cancer.

269 nesterase, bilirubin, type of primary tumor, age at radioembolization, hepatic tumor burden, presence

270 nd point was the development of asthma until age 12 years.

271 reated with methotrexate and eight untreated age-matched control subjects by using Wilcoxon rank-sum

272 Upon aging, hematopoietic stem cells (HSCs) undergo changes i

273 6 individuals in NHANES, the median weighted age was 53 years (interquartile range, 46-61), and 53% (

274 the most important traditional features were age and HRL histologic results (eg, atypical ductal hype

275 All case patients were age and sex matched with control subjects.

276 tients and Methods We evaluated men who were age </= 75 years when diagnosed with localized prostate

277 Eligible participants were aged 6-11 years, weighed 25 kg or more, had virological

278 Participants who were aged at least 18 years with influenza and were at increa

279 e was a significant interaction of BCPR with age.

280 dge of how our biological clocks change with age may create valuable opportunities to improve health

281 MSCs, FOXP1 expression levels declined with age in an inverse manner with those of the senescence ma

282 n the proximal and distal ends declines with age.

283 , analyses included interactions of ECT with age group, sex, race/ethnicity, and diagnosis group.

284 of EV-A71 infection generally increased with age which showed rapid growth in severe cases.

285 tural plasticity of hippocampal neurons with age.

286 d improved visual outcomes for patients with age-related macular degeneration.

287 function and integrity decline rapidly with age, culminating in activity-dependent, non-apoptotic ce

288 brain metabolism evolves significantly with age throughout childhood, limiting their clinical applic

289 Seropositivity increased slightly with age in only one district.

290 steeper decreases in cortical thickness with age.

291 ine surveillance mammography use among women age >/= 65 years who reported a history of breast cancer

292 st in younger age groups (for example, women aged 18-34 years and >/=75 years had 54% [95% confidence

293 atus in over 11,000 breast-cancer-free women aged 35-85 years, from 40 ethnicity- and location-specif

294 Eligible participants were all women, aged 18 to 69 years, who had at least 1 reticular vein w

295 was strongly associated with higher working-age male mortality rates both between 1992 and 1998 (age

296 -59 mo) and women of reproductive age (WRA) (age range: 15-49 y).Cross-sectional data for PSC (8 surv

297 a decade later in life in the 30- to 39-year age range.

298 lt patients (n = 13 096; mean age, 42 years; age range, 15-95 years) admitted with BAPT from January

299 s no significant association between younger age and risk of definitive treatment or risk of biochemi

300 and the differences were greatest in younger age groups (for example, women aged 18-34 years and >/=7